Citadel Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.1M Sell
364,155
-30,086
-8% -$174K ﹤0.01% 2640
2025
Q1
$2.6M Sell
394,241
-592,710
-60% -$3.91M ﹤0.01% 2348
2024
Q4
$8.6M Sell
986,951
-202,044
-17% -$1.76M ﹤0.01% 1420
2024
Q3
$23.2M Buy
1,188,995
+175,852
+17% +$3.44M ﹤0.01% 790
2024
Q2
$20.9M Buy
1,013,143
+994,696
+5,392% +$20.5M ﹤0.01% 853
2024
Q1
$393K Sell
18,447
-1,102,125
-98% -$23.5M ﹤0.01% 4149
2023
Q4
$16.1M Sell
1,120,572
-351,720
-24% -$5.06M ﹤0.01% 958
2023
Q3
$13.4M Sell
1,472,292
-444,323
-23% -$4.05M ﹤0.01% 983
2023
Q2
$20.3M Sell
1,916,615
-18,992
-1% -$201K ﹤0.01% 813
2023
Q1
$23.7M Buy
1,935,607
+1,211,847
+167% +$14.8M 0.01% 771
2022
Q4
$8.98M Buy
723,760
+421,594
+140% +$5.23M ﹤0.01% 1375
2022
Q3
$4.13M Buy
302,166
+194,032
+179% +$2.65M ﹤0.01% 2035
2022
Q2
$1.98M Sell
108,134
-45,599
-30% -$836K ﹤0.01% 2748
2022
Q1
$2.47M Sell
153,733
-115,417
-43% -$1.86M ﹤0.01% 2790
2021
Q4
$3.77M Buy
269,150
+132,692
+97% +$1.86M ﹤0.01% 2382
2021
Q3
$2.56M Buy
136,458
+96,953
+245% +$1.82M ﹤0.01% 2736
2021
Q2
$824K Sell
39,505
-1,395,712
-97% -$29.1M ﹤0.01% 4223
2021
Q1
$40.6M Sell
1,435,217
-1,632,396
-53% -$46.1M 0.01% 572
2020
Q4
$100M Buy
3,067,613
+936,627
+44% +$30.6M 0.03% 216
2020
Q3
$65.3M Buy
2,130,986
+1,149,804
+117% +$35.2M 0.02% 294
2020
Q2
$16M Buy
981,182
+373,228
+61% +$6.08M 0.01% 844
2020
Q1
$6.05M Buy
607,954
+550,149
+952% +$5.47M ﹤0.01% 1322
2019
Q4
$795K Buy
57,805
+42,687
+282% +$587K ﹤0.01% 3189
2019
Q3
$229K Sell
15,118
-286,568
-95% -$4.34M ﹤0.01% 4054
2019
Q2
$5.94M Buy
+301,686
New +$5.94M ﹤0.01% 1537
2019
Q1
Sell
-38,792
Closed -$544K 4825
2018
Q4
$544K Buy
38,792
+10,961
+39% +$154K ﹤0.01% 3227
2018
Q3
$487K Buy
27,831
+2,123
+8% +$37.1K ﹤0.01% 3179
2018
Q2
$468K Buy
+25,708
New +$468K ﹤0.01% 3176